Hillman Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
AWA
Hillman Capital Management's MRK Position: Q4 2022 in Review
Hillman Capital Management sold out of Merck (MRK) in Q4 2022, closing a stake of 66,707 shares — an estimated $5.75M sold.
Hillman Capital Management first reported a position in MRK in Q2 2013 and held it in 15 quarters. The position peaked at $8.95M in Q2 2022. 3,236 funds tracked by Wall St. Rank hold MRK as of Q4 2022.
- Hillman Capital Management reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
- Hillman Capital Management sold 66,707 Merck shares in Q4 2022, an estimated $5.75M.
- Hillman Capital Management first reported a position in Merck in Q2 2013 and held it in 15 quarters.
- Hillman Capital Management's Merck position peaked at $8.95M in Q2 2022.
- 3,236 funds tracked by Wall St. Rank held Merck as of Q4 2022.
Based on Hillman Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.